The Role of ZNF275/AKT Pathway in Carcinogenesis and Cisplatin Chemosensitivity of Cervical Cancer Using Patient-Derived Xenograft Models
Zinc finger protein 275 (ZNF275) is a C2H2-type transcription factor that is localized on chromosome Xq28. Whether ZNF275 participates in modulating the biological behaviors of cervical cancer has not been determined to our knowledge. The present study employed CCK-8, BrdU, flow cytometry, and a tra...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/23/5625 |
_version_ | 1797400397701185536 |
---|---|
author | Miaomiao Ye Tingxian Liu Liqing Miao Shuangwei Zou Huihui Ji Jian’an Zhang Xueqiong Zhu |
author_facet | Miaomiao Ye Tingxian Liu Liqing Miao Shuangwei Zou Huihui Ji Jian’an Zhang Xueqiong Zhu |
author_sort | Miaomiao Ye |
collection | DOAJ |
description | Zinc finger protein 275 (ZNF275) is a C2H2-type transcription factor that is localized on chromosome Xq28. Whether ZNF275 participates in modulating the biological behaviors of cervical cancer has not been determined to our knowledge. The present study employed CCK-8, BrdU, flow cytometry, and a transwell assay to investigate the cell viability, proliferation, apoptosis, migration, and invasion of cervical cancer cells. The application of Western blotting and immunohistochemistry (IHC) aims to assess ZNF275 protein expression and identify the signaling pathway relevant to ZNF275-mediated effects on cervical cancer. The therapeutic impact of the combined therapy of the AKT inhibitor triciribine and cisplatin was evaluated on cervical cancer patient-derived xenograft (PDX) models expressing high ZNF275. The current research illustrated that cervical cancer tissue exhibited a higher expression of ZNF275 in contrast to the surrounding normal cervical tissue. The downregulation of ZNF275 suppressed cell viability, migration, and invasion, and facilitated the apoptosis of SiHa and HeLa cells via weakening AKT/Bcl-2 signaling pathway. Moreover, triciribine synergized with cisplatin to reduce cell proliferation, migration, and invasion, and enhanced the apoptosis of SiHa cells expressing high ZNF275. In addition, the combination treatment of triciribine and cisplatin was more effective in inducing tumor regression than single agents in cervical cancer PDX models expressing high ZNF275. Collectively, the current findings demonstrated that ZNF275 serves as a sufficiently predictive indicator of the therapeutic effectiveness of the combined treatment of triciribine and cisplatin on cervical cancer. Combining triciribine with cisplatin greatly broadens the therapeutic options for cervical cancer expressing high ZNF275, but further research is needed to confirm these results. |
first_indexed | 2024-03-09T01:54:04Z |
format | Article |
id | doaj.art-a288e375ab7e491081a7d3fe7a4eb61c |
institution | Directory Open Access Journal |
issn | 2072-6694 |
language | English |
last_indexed | 2024-03-09T01:54:04Z |
publishDate | 2023-11-01 |
publisher | MDPI AG |
record_format | Article |
series | Cancers |
spelling | doaj.art-a288e375ab7e491081a7d3fe7a4eb61c2023-12-08T15:12:45ZengMDPI AGCancers2072-66942023-11-011523562510.3390/cancers15235625The Role of ZNF275/AKT Pathway in Carcinogenesis and Cisplatin Chemosensitivity of Cervical Cancer Using Patient-Derived Xenograft ModelsMiaomiao Ye0Tingxian Liu1Liqing Miao2Shuangwei Zou3Huihui Ji4Jian’an Zhang5Xueqiong Zhu6Zhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, ChinaZhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, ChinaZhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, ChinaZhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, ChinaZhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, ChinaZhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, ChinaZhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, ChinaZinc finger protein 275 (ZNF275) is a C2H2-type transcription factor that is localized on chromosome Xq28. Whether ZNF275 participates in modulating the biological behaviors of cervical cancer has not been determined to our knowledge. The present study employed CCK-8, BrdU, flow cytometry, and a transwell assay to investigate the cell viability, proliferation, apoptosis, migration, and invasion of cervical cancer cells. The application of Western blotting and immunohistochemistry (IHC) aims to assess ZNF275 protein expression and identify the signaling pathway relevant to ZNF275-mediated effects on cervical cancer. The therapeutic impact of the combined therapy of the AKT inhibitor triciribine and cisplatin was evaluated on cervical cancer patient-derived xenograft (PDX) models expressing high ZNF275. The current research illustrated that cervical cancer tissue exhibited a higher expression of ZNF275 in contrast to the surrounding normal cervical tissue. The downregulation of ZNF275 suppressed cell viability, migration, and invasion, and facilitated the apoptosis of SiHa and HeLa cells via weakening AKT/Bcl-2 signaling pathway. Moreover, triciribine synergized with cisplatin to reduce cell proliferation, migration, and invasion, and enhanced the apoptosis of SiHa cells expressing high ZNF275. In addition, the combination treatment of triciribine and cisplatin was more effective in inducing tumor regression than single agents in cervical cancer PDX models expressing high ZNF275. Collectively, the current findings demonstrated that ZNF275 serves as a sufficiently predictive indicator of the therapeutic effectiveness of the combined treatment of triciribine and cisplatin on cervical cancer. Combining triciribine with cisplatin greatly broadens the therapeutic options for cervical cancer expressing high ZNF275, but further research is needed to confirm these results.https://www.mdpi.com/2072-6694/15/23/5625cervical cancerzinc finger protein 275 (ZNF275)cisplatinchemosensitivitypatient-derived xenograft (PDX) models |
spellingShingle | Miaomiao Ye Tingxian Liu Liqing Miao Shuangwei Zou Huihui Ji Jian’an Zhang Xueqiong Zhu The Role of ZNF275/AKT Pathway in Carcinogenesis and Cisplatin Chemosensitivity of Cervical Cancer Using Patient-Derived Xenograft Models Cancers cervical cancer zinc finger protein 275 (ZNF275) cisplatin chemosensitivity patient-derived xenograft (PDX) models |
title | The Role of ZNF275/AKT Pathway in Carcinogenesis and Cisplatin Chemosensitivity of Cervical Cancer Using Patient-Derived Xenograft Models |
title_full | The Role of ZNF275/AKT Pathway in Carcinogenesis and Cisplatin Chemosensitivity of Cervical Cancer Using Patient-Derived Xenograft Models |
title_fullStr | The Role of ZNF275/AKT Pathway in Carcinogenesis and Cisplatin Chemosensitivity of Cervical Cancer Using Patient-Derived Xenograft Models |
title_full_unstemmed | The Role of ZNF275/AKT Pathway in Carcinogenesis and Cisplatin Chemosensitivity of Cervical Cancer Using Patient-Derived Xenograft Models |
title_short | The Role of ZNF275/AKT Pathway in Carcinogenesis and Cisplatin Chemosensitivity of Cervical Cancer Using Patient-Derived Xenograft Models |
title_sort | role of znf275 akt pathway in carcinogenesis and cisplatin chemosensitivity of cervical cancer using patient derived xenograft models |
topic | cervical cancer zinc finger protein 275 (ZNF275) cisplatin chemosensitivity patient-derived xenograft (PDX) models |
url | https://www.mdpi.com/2072-6694/15/23/5625 |
work_keys_str_mv | AT miaomiaoye theroleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels AT tingxianliu theroleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels AT liqingmiao theroleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels AT shuangweizou theroleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels AT huihuiji theroleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels AT jiananzhang theroleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels AT xueqiongzhu theroleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels AT miaomiaoye roleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels AT tingxianliu roleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels AT liqingmiao roleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels AT shuangweizou roleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels AT huihuiji roleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels AT jiananzhang roleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels AT xueqiongzhu roleofznf275aktpathwayincarcinogenesisandcisplatinchemosensitivityofcervicalcancerusingpatientderivedxenograftmodels |